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http:WHAT THIS PAPER ADDS
Postoperative stump pain after major lower limb amputation is a signiﬁcant impediment to the recovery of
amputees. The vast majority of patients require opioid analgesics following surgery, which are associated with
opioid-related side-effects. Continuous perineural catheter infusions of local anesthetic are a safe and effective
method for reducing opioid analgesic medications following lower limb amputations. This adds to existing
literature and is one of the largest studies to date.Objectives: Postoperative stump pain after major lower limb amputation is a signiﬁcant impediment to the
recovery of amputees. The vast majority of patients require opioid analgesics following surgery, which are
associated with opioid-related side-effects. Here, we investigate whether intraoperative placement of a
peripheral nerve stump catheter followed by continuous infusion of local anesthetic is as effective at pain control
as current analgesic practices. If beneﬁcial, this procedure could potentially reduce post-amputation opioid
consumption and opioid-related adverse effects.
Methods: A retrospective chart review was conducted of 198 patients over a 4-year period who had undergone a
major lower limb amputation for indications related to peripheral vascular disease. Postoperatively, 102 patients
received a perineural catheter were compared to 96 patients who did not. The primary outcomes of this study
were the amount of morphine equivalents used in the ﬁrst 72 hours postoperatively and postoperative pain
intensity in the ﬁrst 24 hours.
Results: A total of 198 lower-limb amputations were selected for analyses. Multiple regression analyses indicated
that perineural catheter use was associated with a lower cumulative postoperative opioid consumption over the
ﬁrst 72 hours but not postoperative pain scores at 24 hours. Perineural catheter use led to a 40% reduction in
opioid use during the ﬁrst 72 hours postoperatively. Mixed model repeated measures analysis demonstrated that
this opioid reduction was consistent over time. Other variables related to total opioid use included age, pre-
surgical chronic pain, pre-surgical opioid use, patient-controlled analgesia.
Conclusions: Continuous perineural infusions of local anesthetic are a safe and effective method for reducing
post-amputation opioid analgesic medications after major lower limp amputation.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Lower limb amputations lead to signiﬁcant disability and up
to w80% of patients will suffer from phantom limb and
stump pains.1e4 Stump pain is a signiﬁcant sequela in the
initial postoperative phase that impedes rehabilitation of
amputees. In addition, the development of chronic pain
following amputation is a long-term complication5 that
greatly impairs quality of life.rresponding author. G. Roche-Nagle, Toronto General Hospital, 200
th Street, Toronto, Ontario M5G 2C4, Canada.
il address: graham.roche-nagle@uhn.ca (G. Roche-Nagle).
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//dx.doi.org/10.1016/j.ejvs.2014.07.002Opioids are the most common agents used to manage
postoperative amputation pain. However, opioids are asso-
ciated with substantial adverse effects including delirium,
nausea, and sedation. These adverse effects are particularly
difﬁcult for elderly patients, who make up the largest pop-
ulation of patients undergoing lower limb amputation.3,6
Regional analgesic techniques7,8 provide simple and effec-
tive methods to reduce acute postoperative pain, opioid
use, and their adverse effects.
In this retrospective chart review we evaluate whether
continuous infusion of local anesthetic via a perineural
catheter is as effective as opioids alone, thus offering
potential for reducing post-amputation pain, opioid con-
sumption, and concomitant adverse effects.
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Approval to conduct the research was obtained from the
University Health Network research ethics board. The hos-
pital charts of 162 patients undergoing major lower limb
amputation between January 2009 and June 2013 were
reviewed. A total of 209 separate amputations were
reviewed. Nine participants were excluded as extreme
outliers (4 catheter, 5 non-catheter), using standard outlier
detection (6 standard deviations or greater).9 An addi-
tional two patients were excluded due to indications un-
related to peripheral vascular disease manifestations (aged
24 and 37 years, both with congenital abnormalities),
leaving 198 amputation cases for analysis (20 were a second
primary amputation and 16 were revisions of primary
amputations).
The 198 amputations were classiﬁed into one of two
groups. The treatment/catheter group consisted of patients
who received a continuous perineural stump catheter
following either a below-knee amputation (BKA) or an
above-knee amputation (AKA). The second group, the
comparison group, also underwent BKA or AKA but did not
receive a perineural stump catheter. As of July 2009, the
division of vascular surgery gradually began introducing the
practice of using stump catheters for limb amputation,
which was driven by a new staff appointment. Patients
were allocated to group (catheter vs. no catheter) based on
the attending surgeon availability. Each surgeon was trained
in the procedure but uptake was variable. The rates of
perineural catheters were variable over the time period
studied (2009: 66%; 2010: 34%; 2011: 72%; 2012: 47%;
2013: 43% of patients receiving catheters in the listed year).
Patients in both groups received postoperative analgesia
with opioids that were delivered parenterally by intrave-
nous (IV) patient-controlled analgesia (IV-PCA), non-PCA
(e.g., oral, transdermal, or nurse-administered IV anal-
gesia), or a combination of both. Patients were advised by
the acute pain service (APS) when given IV-PCA devices to
maintain their pain less than 4/10 (i.e., in the mild rage). At
our institution, the APS includes an attending anesthesiol-
ogist and several nurse practitioners (NPs) who have
specialized training in pain management. The APS is
involved in the care of all patients requiring a PCA device,
an epidural, or a peripheral nerve/stump catheter following
surgery. Patients are visited and care issues discussed daily
to optimize pain control.
The patient records were reviewed for age, gender, level of
amputation, indication for the operation, placement of a
perineural catheter, preoperative pain intensity, duration of
preoperative pain, preoperative painmedication use in the 24
hours prior to the amputation, and comorbidities, speciﬁcally
diabetes, smoking, and chronic pain (greater than 6months in
duration). Postoperative analgesic use during the ﬁrst 72
hours postoperatively was documented and converted to
morphine equivalents (University of Alberta, Faculty of Med-
icine andDentistry,Multidisciplinary Pain Centre; http://www.
uofapain.med.ualberta.ca/en/ForHealthProfessionals/Opioid
ConversionGuide.aspx). Postoperative patient-reported painintensity scores during the ﬁrst 24 hours were recorded on an
11-point numeric rating scale (NRS) (0 is “no pain”, 10 being
the “worst pain imaginable”). Finally, duration of the peri-
neural catheter placement, duration of hospital stay post-
operatively, time to mobilization, and delirium (delirium was
assessed by the Confusion Assessment Method.10 RNs assess
the patients each shift and as required), sedation, and nausea
were also measured.
Placement of the perineural stump catheter
Five different surgeons placed perineural stump catheters
that supplied a continuous infusion of ropivacaine (0.2%,
2e6 mL/hour), bupivicaine (0.25%, 2e5 mL/hour), or lido-
caine (1%, 5e8 mL/hour); 90.20% of catheters delivered
ropivacaine (0.2%).
Using the described technique of Malawer, et al.,11 at the
time of amputation, a 20-gauge polyamide catheter (Portex
4910-16/17) was inserted under direct vision several centi-
meters above the level of transection of either the exposed
sciatic (AKA) or posterior tibial nerve (BKA), depending on
the level of amputation. The catheter was then advanced
cephalad 5e10 cm. The catheter was externalized and
secured. Typically, a 10-mL bolus was injected into the
catheter before wound closure to conﬁrm patency of cath-
eter. Continuous infusion of local anesthetic was commenced
in the recovery room. We limited the infusion volume to
2 mL/hour in the BKAs due to the small compartment space.
Statistical analysis
Standard methods were used to assess the appropriateness
of statistical techniques and to investigate outliers including
standardized scores, probability of Mahalanobis distance
and/or Cooks’s distance as appropriate.9 Of the 165 par-
ticipants, nine were excluded as extreme outliers (4 cath-
eter, 5 non-catheter). Two participants were excluded due
to indications unrelated to peripheral vascular disease,
leaving a total of 198 amputations for analysis. Participant
demographics were compared between catheter and non-
catheter groups using t tests, Fisher exact tests, and chi-
square analyses as appropriate. A Bonferroni correction
was applied to the Type I error rate when comparing pre-
surgical variables, setting alpha at 0.01.
Regression analyses
Independent exposure variables were classiﬁed into ﬁve
categories: (a) demographic variables (gender, age), (b)
preoperative comorbidities (diabetes, chronic pain and
smoking status), (c) pre-surgery measures (pre-surgery pain
level, pre-surgery opioids), (d) PCA status, and (e) perineural
catheter status. The analysis performed in this study is a
three-step series of multiple linear regressions, which are
built up to the ﬁnal linear regression model. The ﬁrst linear
regression involved running each variable (age, sex, etc.) as
its own linear regression in relation to the dependent var-
iable of total opioid use (unadjusted beta). The unadjusted
beta represents the ability of each individual variable to
predict total morphine use. Positive values are associated
Table 1. Demographic and preoperative medical variables.
Catheter
(n ¼ 102)
Non catheter
(n ¼ 96)
Mean age in years (SD) 69.9 (11.78) 66.29 (11.85)
Gender
Male n (%) 65 (48.9) 68 (51.1)
Mean preop 24 hour opioid
in mg (SD)
20.01 (29.99) 15.40 (17.56)
Patient-controlled analgesia,
n (%)
75 (73.5) 74 (77.1)
Diabetes status, n (%) 67 (65.7) 75 (78.1)
Smoking status n (%) 49 (48) 57 (59.4)
History of chronic pain n (%) 32 (31.4) 34 (35.4)
Mean preoperative pain score
(SD)
5.14 (3.44) 4.83 (3.24)
Note. There was no signiﬁcant difference between the groups on
these variables (Bonferroni correction applied for multiple
comparisons).
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ated with decreased opioid use after amputation. Second, a
subsequent multivariate linear regression was conducted
for each group (demographics, comorbidities, etc.) using
signiﬁcant variables from within its group that were ob-
tained from the ﬁrst linear regression (group adjusted beta),
postoperative opioid use was the dependent variable. The
group-adjusted beta score represents the score of each in-
dividual predictor adjusted for the other predictors within
its group in relation to postoperative opioid use (de-
mographic, pre-surgery scores, PCA, comorbidity). Finally, a
third multivariate linear regression was conducted. The ﬁnal
model took all variables that were signiﬁcant predictors of
total opioid use in their respective groups from the second/
group-adjusted linear regression and were used to build the
ﬁnal multivariate linear regression (fully adjusted beta). For
each category of exposure variable listed above, separate
multivariate regression analyses were conducted to ascer-
tain the variables that showed a signiﬁcant relationship with
the dependent variable (postoperative opioid consump-
tion). A complete multivariable model was then created
using all variables found to have a signiﬁcant relationship
with the dependent variable in the previous models, as well
as the main variable of interest (perineural catheter status).
All analyses were conducted with SPSS (IBM, New York,
USA) version 10.05, using a signiﬁcance level of 0.05.
Mixed-model repeated measures ANOVA. A mixed-model
repeated measures ANOVA was conducted on morphine
consumption using time as the within-subjects factor, cath-
eter status as the between-subjects factor and the time by
catheter status interaction term to assess whether the effect
of catheter use on morphine consumption varied by time.
Repeated measures analysis is especially susceptible to the
effects of outliers. Accordingly analyses were run on the
original post-surgical measures of morphine use excluding
the extreme outliers (n ¼ 198), and also on a (logþ1)
transformation of the morphine variables on all participants
used, to acquire a more normal distribution (n ¼ 205).
RESULTS
Descriptive statistics
A total of 162 individual patients underwent 198 lower limb
amputations (20 were second primary contralateral ampu-
tations and 16 were revisions of previous ipsilateral am-
putations) for peripheral vascular disease (67% male, 33%
female), with an average age of 68 years. Demographics,
comorbidities, and perioperative variables are presented in
Table 1. There were no signiﬁcant differences between the
catheter and non-catheter groups in gender, age, previous
chronic pain, smoking status, diabetes status, preoperative
pain scores, preoperative 24-hour opioid, or above knee vs.
below knee assignment in surgery (all p > .05).
Postoperative opioid use
The use of analgesic medications was converted to
morphine equivalents. Multivariable regression analysis wasused to determine which variables were related to post-
operative opioid use. Stump catheter use was associated
with a signiﬁcantly lower total postoperative opioid use
(catheter 81.23  90.77 vs. non-catheter 134.51  145.49,
p ¼ .03).
In the initial multivariable regression models (see
Methods), age, and perineural catheter use were associ-
ated with signiﬁcantly less total opioid use in the ﬁrst 72
hours postoperatively. While chronic pain, preoperative
opioid use, and PCA status were signiﬁcantly associated
with increased total opioid use after amputation (Table 2).
In the full multivariable model, all these variables
remained signiﬁcant. With the above-listed variables held
constant, perineural catheter use remained a signiﬁcant
predictor of lower total post-surgical opioid use (p ¼ .004).
There was a decrease in total opioid with increased age,
while preoperative opioid use, PCA use, and preoperative
chronic pain were all associated with an increase in total
opioid use.
Mixed-model repeated measures ANOVA
Table 3 summarizes the average opioid use at each interval
by catheter status (n ¼ 198). As seen in the average total
72-hour opioid use, patients given a perineural catheter
used, on average, 40% less opioid than those not receiving a
perineural catheter (T ¼ 3.11, p ¼ .03). Total opioid use was
also examined during three post-surgery time frames: 0e24
hours, 24e48 hours, and 48e72 hours. The time by cath-
eter status interaction was non-signiﬁcant (p > .22), indi-
cating that the opioid sparing effect seen with perineural
catheter use does not differ signiﬁcantly as a function of the
time frame sampled, while the overall between-subject ef-
fect of perineural catheter use was signiﬁcant (p ¼ .03).
Use of non-opioid analgesics
There was no difference between the catheter and non-
catheter group in the relative use of gabapentin (catheter
40 of 102, 39.22% vs. non-catheter 35 of 96, 36.46%,
p ¼ .77).
Table 2. Multivariate linear regressions with adjusted and unadjusted beta for the association between demographic variables and total post-surgical opioid use.
Cases (n ¼ 102) Comparison group
(n ¼ 96)
Single variable unadjusted
beta (95% CI)
Within group adjusted
beta (95% CI)a
Fully adjusted beta (95% CI)b p-values for fully
adjusted beta results
Mean age (SD) 69.9 (11.78) 66.29 (11.85) 4.59 (5.89 to 3.28) 4.62 (5.92 to 3.33) 3.46 (4.70 to 2.22) <.0001
Sex n (%)
Male 65 (48.9) 68 (51.1)
Female 37 (56.9) 28 (43.1) 25.48 (11.16 to 62.13) 29.30 (3.52 to 62.14)
Catheter status n (%)
Catheter 102 (100) d 53.28 (87.05 to 19.50) d 42.88 (71.76 to 14.01) .004
No catheter d 96 (100)
History of chronic pain n (%)
Yes 32 (31.4) 34 (35.4) 75.67 (40.58 to 110.77) 72.75 (36.94 to 108.57) 50.16 (18.45 to 81.86) .002
No 70 (68.6) 62 (64.6)
Mean preop 24-hour opioid (SD) 20.01 (29.99) 15.40 (17.56) 1.90 (1.25 to 2.55) 1.51 (0.70 to 2.23) 1.17 (0.54 to 1.80) <.0001
Patient-controlled analgesia n (%)
Yes 75 (73.5) 74 (77.1) 45.40 (5.84 to 84.95) d 35.68 (2.34 to 69.03) .036
No 27 (26.5) 22 (22.9)
Diabetes status n (%)
Yes 67 (65.7) 75 (78.1) 24.73 (63 to 13.5) 26.69 (63.39 to 10.02)
No 35 (28.3) 21 (21.9)
Smoking status n (%)
Yes 49 (48) 57 (59.4) 28.31 (6.13 to 62.75) 15.11 (18.78 to 48.99)
No 53 (52) 39 (40.6)
Mean preoperative pain score (SD) 5.14 (3.44) 4.83 (3.24) 7.83 (1.59 to 14.06) 5.06 (0.98 to 11.10)
a Adjusted for group variables only. While unadjusted beta represents each individual measures ability to predict total opioid use, this score represents the score of each individual predictor
adjusted for the other predictors in its group (demographic, pre-surgery scores, PCA, comorbidity).
b Adjusted for all variables that were signiﬁcant predictors of total morphine use in their respective groups (demographics, pre-surgery scores, PCA and comorbidity). Variable(s) signiﬁcant in
the ﬁnal model are age, catheter status, pre-surgical opioid use, PCA status, and pre-surgical chronic pain.
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Table 3. Mean (SD) opioid use in milligrams during 0e24, 24e48,
and 48e72 hour post-surgery time frames by treatment group.
Time frame Perineural catheter Non-catheter
0e24 hours 30.28 (33.17) 50.53 (55.88)
24e48 hours 26.92 (34.84) 46.42 (60.30)
48e72 hours 24.85 (36.30) 36.95 (44.44)
72-hour total 81.23 (90.77) 134.51 (145.49)*
*p ¼ .03.
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Postoperatively, multiple regression analysis revealed no
difference between the catheter and non-catheter groups
in total pain after amputation. In both groups the average
24-hour postoperative pain intensity was low (catheter
3.02  2.12 vs. non-catheter 3.38  2.12).
Above-knee versus below-knee amputations
Surgeries in this study were a roughly equal mix of AKA and
BKA cases (109 AKA vs. 89 BKA). There was no signiﬁcant
difference in the amount of opioid used between AKA and
BKA groupings postoperatively (AKA 104.92  110.86 vs.
BKA 109.68  137.14; p ¼ .79). Pain levels were signiﬁ-
cantly lower for AKAs than BKAs (AKA 2.81  2.13 vs. BKA
3.66  2.03 p ¼ .046, CI 6.0 to 0.14).
Mobilization after amputation
The number of days to sit up in bed (catheter 1.86  1.21
days vs. non-catheter 1.61  0.85 days, p ¼ .21) or to
mobilize out of bed within 3 days after amputation (cath-
eter 27.28% [18 of 66] vs. non-catheter 20.00% [9 of 45],
p ¼ .51) were not different between the catheter and non-
catheter groups.
Adverse events
Delirium. The one-sided Fisher exact test was used to
examine the hypothesis that lower opioid use in the cath-
eter group would be associated with lower levels of post-
surgical delirium. The results revealed a trend for delirium
levels to be lower in the catheter group (n ¼ 207; p ¼ .054).
Sedation and nausea. The occurrence of sedation (catheter
3 patients vs. non-catheter 5 patients) and nausea (catheter
1 vs. non-catheter 1) were very low and precluded statis-
tical analyses.
Catheter failure. Perineural catheters remained in place for
an average of 3.89  1.34 days (range 1e7). Nine catheters
failed, ﬁve became blocked, two were disconnected by the
patient, one line became kinked, and one was incompletely
inserted in the operating room. Although failure occurred in
8.8% (9 of 102) of the catheters there was no difference in
the average time to discharge from the hospital following
amputation (catheter 17.00  13.26 days vs. non-catheter
17.88  14.06 days; p ¼ .670). The yearly failure rate of
catheters was low and the rates decreased from year to
year (2009: 18.75% [3 of 16]; 2010: 12.5% [2 of 16]; 2011:
9.1% [3 of 33]; 2012: 4.0% [1 of 25]; 2013: 0% (0 of 12).Deaths. There were eight in-hospital deaths in this sample
(catheter 5; non-catheter 3). Chi-square analysis revealed
no signiﬁcant differences in the number of deaths based on
catheter status (p ¼ .33).DISCUSSION
This retrospective chart review of 198 consecutive ampu-
tations showed that continuous infusion of local anesthetic
via perineural catheters is an effective tool to reduce opioid
analgesic consumption following lower limb amputation. In
the present study, although postoperative pain was well
managed in both groups a signiﬁcant between-group dif-
ference in pain scores did not emerge. The use of perineural
catheters provided equivalent postoperative pain control
relative to the comparison group with signiﬁcantly less
opioid usage.
Previously, it has been reported that perineural analgesia
at the surgical site is a safe and effective method that leads
to a signiﬁcant reduction in postoperative opioid con-
sumption for patients undergoing various surgeries.3,12e17
Several previous studies have examined the use of peri-
neural catheters to control postoperative amputation pain
but have produced varied results with small sample
sizes.3,14,16,18e21
This current study is the largest evaluation of perineural
infusion catheters following lower limb amputations. Our
results indicate that the use of perineural infusion catheters
effectively reduces post-amputation consumption of opioid
analgesics with comparable pain scores up to 24 hours. The
ability to reduce opioid consumption after amputation but
to still maintain adequate pain control is particularly
important for patients of advanced age who may be more
susceptible to the side-effects of opioids.3 Although we
investigated whether there was a decrease in delirium
following lower limb amputation with perineural catheter
use, this study was underpowered to have found it. Peri-
neural catheter use was found to be safe and failure rates
were low without an increase in adverse events, which is in
line with previous studies.3,14,16,18e20
In addition to the side effects of opioid analgesics, post-
amputation pains are a signiﬁcant problem for patients
recovering from lower limb amputations. We were unable
to ﬁnd any differences in the patient-reported pain scores
between the comparison group and the catheter group.
Patients in both groups had their pain very well controlled
while in hospital.20 The low levels of postoperative pain in
each group support this conclusion. In studies where pain is
well controlled, the level of pain medications required by
patients may be a better means to assess the efﬁcacy of
analgesic regimens such as perineural catheters. Impor-
tantly, we noted no differences between AKA and BKA
groups in their levels of postoperative opioid use.
There are several limitations to this study. First, given the
retrospective nature of the data collected, adequate stan-
dardization of postoperative care cannot be assured. Sec-
ond, there may be a surgeon bias to provide patients with
higher morbidity a perineural catheter. Third, due to the
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conﬁdence intervals in the analyses were large. Finally, pain
data were not available beyond 24 hours after patients
were discharged from the APS.
In this report we did not address whether perineural
stump catheters are able to reduce phantom limb pains
after amputation. Previous reports after lower limb ampu-
tation have suggested that perineural catheters may be
effective in reducing phantom limb pains.3,14,19 However,
phantom limb pain is a complex phenomenon that likely
develops due to a combination of pre-amputation pain1,22e
24 as well as the transection of nerves at the time of surgery,
and ectopic activity from the transected ﬁbers after sur-
gery.25 Based on the results presented here a large ran-
domized, double-blinded study with clear endpoints should
be implemented. A prospective study would enable inves-
tigation into the possibility of effectively lowering rates of
stump and phantom limb pains.3,14,25e27
In conclusion, continuous perineural catheter infusions of
local anesthetic are a safe and effective method for
reducing opioid analgesic medications following lower limb
amputations.
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